TOLERABILITY OF A NEW HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% PREPARATION IN PRIMARY IMMUNODEFICIENCY DISEASES

被引：0
|
作者：
Gupta, S.
Stein, M.
Melamed, I.
Hussain, I.
Paris, K.
Engl, W.
Mccoy, B.
Rabbat, C.
Yel, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2016年 / 117卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
O015
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] Tolerability of a new human immune globulin subcutaneous, 20% preparation in patients with primary immunodeficiency diseases
    Andre, Gladiator
    Michelle, Tran
    Gupta, Sudhir
    Iftikhar, Hussain
    Kenneth, Paris
    Werner, Engl
    Barbara, McCoy
    Christopher, Rabbat J.
    Leman, Yel
    SWISS MEDICAL WEEKLY, 2017, 147 : 54S - 55S
  • [2] SAFETY/TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
    Paris, K.
    Derfalvi, B.
    Hussain, I.
    Haddad, E.
    Dicso, F.
    Darter, A.
    Doralt, J.
    Engl, W.
    Mccoy, B.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S97 - S97
  • [3] Immune Globulin Subcutaneous (Human) 20% In Primary Immunodeficiency Disorders
    McCormack, Paul L.
    DRUGS, 2012, 72 (08) : 1087 - 1097
  • [4] Immune Globulin Subcutaneous (Human) 20%In Primary Immunodeficiency Disorders
    Paul L. McCormack
    Drugs, 2012, 72 : 1087 - 1097
  • [5] IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) 20% SOLUTION ADMINISTRATION IN PRIMARY IMMUNODEFICIENCY DISEASES: A RETROSPECTIVE CHART REVIEW
    Rosenbach, K.
    Park, M.
    Sanchirico, M.
    Nwose, O.
    Paris, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S38 - S39
  • [6] A New Subcutaneous Immune Globulin (HyQvia) for Primary Immunodeficiency
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1476): : 121 - 122
  • [7] Onboarding Experience of Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin 10%
    Gupta, Sudhir
    Hussain, Iftikhar
    Paris, Kenneth
    Stein, Mark
    McCoy, Barbara
    Wang, Ping
    Rabbat, Christopher J.
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB26 - AB26
  • [8] Onboarding Experience of Pediatric Patients With Primary Immunodeficiency Diseases With Subcutaneous Human Immune Globulin 20% (Ig20Gly)
    Paris, Kenneth
    Hussain, Iftikhar
    Gupta, Sudhir
    Wang, Ping
    Mccoy, Barbara
    Rabbat, Christopher J.
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB268 - AB268
  • [9] Infusion Parameters and Adverse Events in Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin
    Hussain, Iftikhar
    Paris, Kenneth
    Darter, Amy
    Kobrynski, Lisa J.
    Berner, Todd
    Mccoy, Barbara
    Wang, Ping
    Rabbat, Christopher J.
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB267 - AB267
  • [10] Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%
    Paris, Kenneth
    Haddad, Elie
    Hussain, Iftikhar
    Brodszki, Nicholas
    Darter, Amy Liebl
    Engl, Werner
    Mccoy, Barbara
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB217 - AB217
12345